CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study

INTRODUCTION: Due to their low CNS penetrance, there are concerns about the capacity of non-conventional PI-based ART (monotherapy and dual therapies) to preserve neurocognitive performance (NP). METHODS: We evaluated the NP change of aviremic participants of the SALT clinical trial [1] switching th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez Valero, Ignacio, Pasquau, Juan, Rubio, Rafael, Ribero, Antonio, Santos, Jose, Sanz, Jesus, Mariño, Ana, Crespo, Manel, Hernandez, Jose, Antonio Iribarren, Jose, Gutierrez, Felix, Terron, Alberto, Esteban, Herminia, Antonio Pérez-Molina, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P124
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225372/
https://www.ncbi.nlm.nih.gov/pubmed/25394160
http://dx.doi.org/10.7448/IAS.17.4.19656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225372/
https://www.ncbi.nlm.nih.gov/pubmed/25394160
http://dx.doi.org/10.7448/IAS.17.4.19656

Ejemplares similares